NOS3 and metabolic syndrome: Furthermore, it has been reported that, even though eNOS-derived NO has an anti-atherosclerotic effect, and even though eNOS-KO mice exhibit accumulation of cardiovascular risk factors resembling human metabolic syndrome [27], eNOS-KO mice do not develop atherosclerotic vascular lesions.